Melevodopa
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
|
|
| Identifiers | |
| CAS Number | 7101-51-1 |
| ATC code | N04BA04 |
| PubChem | CID: 23497 |
| ChemSpider | 21968  |
| UNII | M30686U4X4 |
| KEGG | D07304 |
| Chemical data | |
| Formula | C10H13NO4 |
| Molecular mass | 211.215 g/mol |
|
|
|
|
| (verify) |
Melevodopa is a dopaminergic agent. It is the methyl ester of levodopa. It is used in tablet form as an effervescent prodrug with 250 times higher water solubility compared to tablet levodopa.[1]
See also[edit]
References[edit]
- ^ Patrick Hickey and Mark Stacy (2011). "Available and emerging treatments for Parkinson’s disease". Drug Des Devel Ther 5: 241–254. doi:10.2147/DDDT.S11836. PMC 3096539. PMID 21607020.
|
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
